These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 24954624)

  • 1. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes.
    Albers JW; Pop-Busui R
    Curr Neurol Neurosci Rep; 2014 Aug; 14(8):473. PubMed ID: 24954624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].
    Hilz MJ; Marthol H; Neundörfer B
    Fortschr Neurol Psychiatr; 2000 Jun; 68(6):278-88. PubMed ID: 10923253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation as a Therapeutic Target for Diabetic Neuropathies.
    Pop-Busui R; Ang L; Holmes C; Gallagher K; Feldman EL
    Curr Diab Rep; 2016 Mar; 16(3):29. PubMed ID: 26897744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenic Mechanisms of Diabetic Neuropathy].
    Sango K; Yako H; Takaku S; Niimi N
    Brain Nerve; 2024 May; 76(5):671-680. PubMed ID: 38741511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for diabetic neuropathy.
    Tahrani AA; Askwith T; Stevens MJ
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):661-83. PubMed ID: 20795891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.
    Obrosova IG; Julius UA
    Curr Vasc Pharmacol; 2005 Jul; 3(3):267-83. PubMed ID: 16026323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management.
    Jensen TS; Karlsson P; Gylfadottir SS; Andersen ST; Bennett DL; Tankisi H; Finnerup NB; Terkelsen AJ; Khan K; Themistocleous AC; Kristensen AG; Itani M; Sindrup SH; Andersen H; Charles M; Feldman EL; Callaghan BC
    Brain; 2021 Jul; 144(6):1632-1645. PubMed ID: 33711103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic neuropathy. Current concepts on etiopathogenesis, diagnosis, and treatment].
    Zorrilla Hernández E; Frati Munari A; Lozano Castañeda O; Villalpando Hernández S; Boulton AJ
    Gac Med Mex; 1994; 130(1):18-25. PubMed ID: 7557046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic neuropathy in elderly patients. What can be done?
    Belmin J; Valensi P
    Drugs Aging; 1996 Jun; 8(6):416-29. PubMed ID: 8736625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-Related Neurological Implications and Pharmacogenomics.
    Rojas-Carranza CA; Bustos-Cruz RH; Pino-Pinzon CJ; Ariza-Marquez YV; Gomez-Bello RM; Canadas-Garre M
    Curr Pharm Des; 2018; 24(15):1695-1710. PubMed ID: 28322157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications: neuropathy, pathogenetic considerations.
    Greene DA; Sima AA; Stevens MJ; Feldman EL; Lattimer SA
    Diabetes Care; 1992 Dec; 15(12):1902-25. PubMed ID: 1464245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diabetic neuropathies: practical and rational therapy.
    Singleton JR; Smith AG
    Semin Neurol; 2012 Jul; 32(3):196-203. PubMed ID: 23117944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic neuropathy: therapies on the horizon.
    Mahmood D; Singh BK; Akhtar M
    J Pharm Pharmacol; 2009 Sep; 61(9):1137-45. PubMed ID: 19703362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging therapies for diabetic neuropathy: a clinical overview.
    Perkins BA; Bril V
    Curr Diabetes Rev; 2005 Aug; 1(3):271-80. PubMed ID: 18220603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for diabetic neuropathy.
    Bril V
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():22-7. PubMed ID: 22548619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of diabetic neuropathy].
    Jasik M
    Przegl Lek; 2003; 60(3):167-9. PubMed ID: 14575019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion.
    Terashima T; Kojima H; Chan L
    FASEB J; 2012 Jan; 26(1):295-308. PubMed ID: 21978940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies for diabetic neuropathy.
    Habib AA; Brannagan TH
    Curr Neurol Neurosci Rep; 2010 Mar; 10(2):92-100. PubMed ID: 20425233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.